2.301 - 2.325 of 34.391
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Novo Nordisk Call 505,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 10,35x
- Analysis
- Novo Nordisk Call 445,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,68x
- Analysis
- Novo Nordisk Call 505,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,06x
- Analysis
- Novo Nordisk Call 365,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,96x
- Analysis
- Novo Nordisk Call 335,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,57x
- Analysis
- Novo Nordisk Call 345,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,69x
- Analysis
- Novo Nordisk Call 305,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,19x
- Analysis
- Novo Nordisk Call 325,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,46x
- Analysis
- Novo Nordisk Call 545,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,27x
- Analysis
- Novo Nordisk Call 295,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,05x
- Analysis
- Novo Nordisk Call 285,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 2,92x
- Analysis
- Novo Nordisk Call 345,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,45x
- Analysis
- Novo Nordisk Call 405,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 5,44x
- Analysis
- Novo Nordisk Call 465,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,85x
- Analysis
- Novo Nordisk Call 505,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,53x
- Analysis
- Novo Nordisk Call 495,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,31x
- Analysis
- Novo Nordisk Call 535,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,38x
- Analysis
- Novo Nordisk Call 455,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,11x
- Analysis
- Novo Nordisk Call 515,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,26x
- Analysis
- Novo Nordisk Call 465,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,14x
- Analysis
- Novo Nordisk Call 335,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 4,28x
- Analysis
- Novo Nordisk Call 305,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 3,56x
- Analysis
- Novo Nordisk Call 545,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 8,85x
- Analysis
- Novo Nordisk Call 405,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 12,05x
- Analysis
- Novo Nordisk Call 445,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 5,89x
- Analysis